Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TINSAL-CVD
NCT00624923Phase 3Completed
- Sponsor
- Joslin Diabetes Center
- Start
- Sep 2008
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Amigesic in coronary artery disease (CAD), sponsored by Joslin Diabetes Center. Started Sep 2008; status: completed.
02
Drugs
Amigesic
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00624923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624923.